SCHEMBL4813079

SCHEMBL4813079

COC(=O)c1cc2c(o1)CCCC2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
POLB P06746 4/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 4/20 0.45
L3MBTL1 Q9Y468 3/20 0.43
KMT2A Q03164 2/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
KDM4E B2RXH2 5/20 0.38
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
TSHR P16473 4/20 0.36
MEN1 O00255 1/20 0.36
BAZ2B Q9UIF8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18073236 0.82 ALDH1A1 (0.53) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL2417478 0.80 POLB (0.64) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL3548365 0.79 NPC1 (0.46) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL5455490 0.79 POLB (0.46) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL27158601 0.79 POLB (0.46) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL6996600 0.76 POLB (0.37) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL6996604 0.76 POLB (0.37) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL19736948 0.72 TSHR (0.36) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL27883876 0.72 ALDH1A1 (0.44) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19
SCHEMBL10426958 0.71 TDP1 (0.53) ALDH1A1POLBSMN1; SMN2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110770233-B Fused bicyclic compound and application thereof in medicine 广东东阳光药业有限公司 2022-07-26 CN disclosed
CN-110770233-A Fused bicyclic compound and application thereof in medicine 广东东阳光药业有限公司 2020-02-07 CN disclosed
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2008-06-12 US disclosed
US-7368572-B2 Acetylene derivatives as inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2008-05-06 US disclosed
EP-1656348-B1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARM INC (US) 2007-02-07 EP disclosed
EP-1656348-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARMACEUTICALS, INC. (US) 2006-05-17 EP disclosed
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2005-06-16 US disclosed
WO-2005019174-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARMACEUTICALS, INC. (US) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC10, HDAC2 ALDH1A1 429/4885POLB 433/4885SMN1; SMN2 3020/4885
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase HDAC1, HDAC10, HDAC2 ALDH1A1 429/4885POLB 433/4885SMN1; SMN2 3020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.